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Summary
Around the world, human populations have experienced large increases in average
lifespan over the last 150 years, and while individuals are living longer, they are
spending more years of life with multiple chronic morbidities. Researchers have
used numerous laboratory animal models to understand the biological and environ-
mental factors that influence aging, morbidity, and longevity. However, the most
commonly studied animal species, laboratory mice and rats, do not experience envi-
ronmental conditions similar to those to which humans are exposed, nor do we
often diagnose them with many of the naturally occurring pathologies seen in
humans. Recently, the companion dog has been proposed as a powerful model to
better understand the genetic and environmental determinants of morbidity and
mortality in humans. However, it is not known to what extent the age-related
dynamics of morbidity, comorbidity, and mortality are shared between humans and
dogs. Here, we present the first large-scale comparison of human and canine pat-
terns of age-specific morbidity and mortality. We find that many chronic conditions
that commonly occur in human populations (obesity, arthritis, hypothyroidism, and
diabetes), and which are associated with comorbidities, are also associated with sim-
ilarly high levels of comorbidity in companion dogs. We also find significant similari-
ties in the effect of age on disease risk in humans and dogs, with neoplastic,
congenital, and metabolic causes of death showing similar age trajectories between
the two species. Overall, our study suggests that the companion dog may be an
ideal translational model to study the many complex facets of human morbidity and
mortality.
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1 | INTRODUCTION
Age is the greatest risk factor not only for the probability of death,
but also for the majority of morbidities associated with mortality
(Finkel, 2005; Kaeberlein, Rabinovitch & Martin, 2015; Kennedy
et al., 2014). However, studies to identify factors that alter patterns
of aging using animal models have focused on lifespan and age-spe-
cific mortality, rather than the underlying patterns of morbidity that
lead to death. This gap is due in part to the difficulty of measuring
causes of mortality in the standard animal models in aging studies.
For example, age-related morbidity and causes of mortality in the
commonly studied models of aging range from the not well
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understood (and often not studied) in mice (Simms & Berg, 1957;
Snyder, Ward & Treuting, 2016), to the poorly understood in flies
and worms (but see Herndon et al., 2002; Rera, Clark & Walker,
2012), to nonexistent in yeast. In addition, many diseases important
to human aging (e.g., cardiovascular disease and dementia) do not
develop spontaneously in our commonly studied model organisms.
To this end, we need a model organism that allows us to understand
not only age-related mortality, but also age-related morbidity and
causes of death. The companion dog (i.e., dogs that reside under
their owner’s care) has the potential to fill this gap and to enable us
to better understand the genetic and environmental factors that
affect lifespan, and the underlying forces that shape age-specific
morbidity and mortality.
Over the last 200 years, individual dog breeds have been highly
inbred, with the result that genetic variation is relatively limited
within breeds, but considerable among breeds (Leroy, Verrier, Meri-
aux & Rognon, 2009; Ostrander, Wayne, Freedman & Davis, 2017;
Sutter et al., 2004). Thanks in large part to this history of intense
breeding for specific morphological and behavioral traits, dogs are
the most phenotypically diverse mammalian species on the planet.
This diversity is found not only in morphology and behavior, but also
in life-history traits, where across breeds, dogs exhibit an almost
twofold difference in average longevity (Bonnett & Egenvall, 2010;
Fleming, Creevy & Promislow, 2011), and enormous variation in risk
of specific diseases (Fleming et al., 2011). In addition, companion
dogs live in diverse environments and often in close proximity with
their owners. A tightly controlled environment in the laboratory may
be ideal for some scientific questions, but because we share our
environment closely with dogs, they offer us the opportunity to
assess how environment influences morbidity and mortality in dogs
as well as our own species.
Dogs also have a sophisticated veterinary healthcare system, sec-
ond only to that of humans, allowing clinicians to diagnose and treat
specific diseases, and to identify exact causes of death (American
Veterinary Association). For example, unlike mice, companion dogs
experience a diversity of spontaneously occurring diseases similar to
those of humans, such as age-related neurologic disease (Head,
2011), renal disease (Cianciolo, Benali & Aresu, 2016), endocrine dis-
ease (e.g., De Bruin et al., 2009; Fall, Hamlin, Hedhammar, Kampe &
Egenvall, 2007), and also experience obesity and its attendant risks
(German, Ryan, German, Wood & Trayhurn, 2010). These phenom-
ena allow researchers not only to study the pathologies that influ-
ence mortality, but also to understand different comorbidities and
multiple chronic conditions that canines exhibit. In previous work,
we showed that multimorbidity in the dog increases with age (Jin,
Hoffman, Creevy, O’Neill & Promislow, 2016), similar to patterns
seen in humans. As we discuss here, the domestic dog could be a
useful model to understand how comorbidities, both as cause and
consequence, are associated with aging in humans.
Surprisingly, while we know a great deal about the age-specificity
of human morbidity, substantially less is known about the degree to
which other species, including dogs, show similar disease-specific
patterns of aging. Such comparisons are critical in our efforts to
develop powerful models to identify the genetic and environmental
determinants of morbidity and mortality. Here, we present a compar-
ative analysis of causes of mortality in both humans and companion
dogs. We determine the extent to which the companion dog may
provide an excellent model of human aging and the degree to which
causes of mortality correlate between the two species. Our results
lay the groundwork for future use of the domestic dog as a model
of human aging and longevity.
2 | RESULTS
We obtained morbidity and mortality data from 112,375 humans
from the U.S. Census Bureau’s National Longitudinal Mortality Study,
73,835 dogs in the Veterinary Medical Database (VMDB, 37,480 of
which remained after removal of individuals with “unclassified”
pathophysiological process [PP] or organ system [OS] and were used
for comorbidity PP/OS analysis, see Methods), and 5,095 dogs in
the VetCompass Programme database in the United Kingdom. Using
the Census human data and VMDB canine data, we were able to
compare eight PP and nine OS categories between the two species.
There were a total of 106 different possible causes of death for the
Census dataset, and these were assigned to a total of 38 of 72 pos-
sible PP9OS combinations. For the VMDB, 5563 different diagnoses
were recorded representing 93 PP9OS combinations. The VetCom-
pass dataset had 56 diagnoses that were not able to be placed into
PP and OS cause of death, and which had no information on comor-
bidity, and as such were only used for longevity analysis.
We first attempted to determine whether survivorship curves in
humans and dogs were similar. Overall trends were similar between
the two species (Figure 1a), with females being longer lived than
males. However, our Cox proportional hazard model showed only a
minor effect of sex on longevity in dogs, as reported previously from
the data (Hoffman, O’Neill, Creevy & Austad, 2017), while there was
a much larger effect in humans (Cox proportional hazard, p = .017
for dogs, p < .001 for humans). Similar results are seen in our hazard
plots (Figure 1b), where human males have increased mortality com-
pared to females at all ages, with no sex effect seen in dogs. The
slopes of the hazard curves suggest significant differences in the
rates of aging in the two species, especially in the earliest ages, with
dogs having higher starting hazards as compared to humans (Fig-
ure 1b, Gomperz slopes—humans: 0.089 (females) and 0.080 (males),
and dogs: 0.0214 (females) and 0.0219 (males)).
2.1 | Canine multimorbidity and comorbidity
analysis
We first looked at the effect of age and sex on multimorbidity
(counts of all diagnoses at time of death from the VDMB data) using
a generalized linear model (GLM) with a negative binominal distribu-
tion. Our analysis indicated a significant positive association between
age and number of morbidities (p < .001), but no significant effect of
sex on morbidity count (p = .97, Figure S1). We then determined
2 of 13 | HOFFMAN ET AL.
how PP and OS categorical causes of death were associated with
multimorbidity count (Figures S2 and S3). After controlling for the
effects of age, there was no association between PP cause of death
and total counts of morbidities. However, OS cause of death did
have a significant association with morbidity count, even after con-
trolling for the effects of dog age. In particular, dogs that died of
urogenital and hepatic causes had higher numbers of morbidities
than dogs dying of other causes (Figure S3). As in our analysis of the
effects of sex on multimorbidity number after controlling for age,
sex had no significant effect on morbidity number in either the PP
or OS model (p > .27 for both).
We next investigated the morbidity count associated with each
of five specific chronic conditions in dogs (comorbidity analysis) and
found that having a diagnosis of any of four conditions—diabetes
mellitus, arthritis, obesity, and hypothyroidism—was associated with
an increase in comorbidity number (p < .0002 for all specific mor-
bidities, Figure S4). Arthritis, obesity, and hypothyroidism show more
than double the number of comorbidities as compared to the overall
dataset. Dogs diagnosed with chronic kidney disease did not show a
significant increase in comorbidities compared to the overall popula-
tion (p = .84). Similar to our multimorbidity analysis (combined num-
ber of diagnoses), our comorbidity analysis (number of diagnoses a
dog had when one was a morbidity of interest) did not point to a
significant effect of sex on number of comorbidities.
2.2 | Human–dog comparisons
The major objective of this study was to explore shared patterns in
causes of death between humans and dogs. Across PP categories,
we discovered many PP causes of death that showed similar propor-
tions between dogs and humans. However, the overall correlation
between humans and dogs in causes of death was not significant via
a Spearman rank test (Spearman q = 0.238, df = 6, p = .58, Fig-
ure 2a). The largest difference between the two species is seen with
respect to vascular causes of death, which are much more prevalent
in the human population. When this category is removed, we see a
significant correlation among the remaining seven PP causes (Spear-
man q = 0.857, df = 5, p = .024).
We found a significant correlation in rates of death due to OS
categories in humans and dogs (Spearman q = 0.733, df = 7,
p = .031, Figure 2b). While large differences were seen in propor-
tions of respiratory, gastrointestinal, and urogenital causes of death
between humans and dogs, the proportion of neoplastic deaths is
nearly identical between the two species (25.3% in humans; 27.4%
in dogs; Figure 2c), although cancer risk is generally greater in large-
breed than small-breed dogs (Fleming et al., 2011). Despite the simi-
larity in risk of death due to neoplasia among humans and canines,
the types of cancer seen in each species are only marginally corre-
lated (Spearman rank q = 0.661, df = 7, p = .053).
After comparing overall causes of death between the two spe-
cies, we determined how age trajectories of different causes of
death compared between the two species. For many PP categories,
very similar age trajectories are seen, especially for neoplastic, con-
genital, toxic, and metabolic causes of death (Figure 3). For traumatic
death, mortality in humans was biased toward young adults, a pat-
tern also observed in dogs. Our odds ratio analysis suggests age tra-
jectories for risk of both metabolic and neoplastic deaths are similar
between dogs and humans except at the earliest ages (when deaths
are rare), while vascular diseases are much more common in humans
compared to dogs (Figure S5). Controlling for age, risk of cancer is
most similar between humans and dogs for a human age of 53 years
and a dog age of 11.5 (odds ratio close to zero). On the other hand,
the odds that a human death at age 75 has a vascular cause is over
26 = 32 times larger than it is for dogs at the appropriately scaled
age (65 human years), with a log odds ratio greater than 6 (Fig-
ure S5).
We next compared human and canine age trajectories for OS
categorical causes of death. Endocrine and hepatic causes of death
show very similar age trajectories, while many of the other OS
causes of death do not (Figure 4). The only major outlier is the age
trajectory for cardiovascular categorical causes of death, which is
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F IGURE 1 Survivorship (a) and hazard curves for (b) for human
(left) and dogs (right). Human data are from the U.S. Census Bureau
(1972–2002), and canine data come from the VetCompass database
(2010–2013). For both species, colors represent the two sexes,
female (red) and male (blue). Gompertz slope parameters were
calculated for humans: 0.089 (females) and 0.080 (males), and dogs:
0.0214 (females) and 0.0219 (males)
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different both in shape (increasing throughout life in humans, steady
in dogs) and magnitude (higher percentage in humans). The log odds
ratio plots demonstrate that cardiovascular causes of death are as
much as 23 = eight times higher in humans at late age while hepatic
and metabolic causes of death are more common among dogs at late
age (Figure S6).
In addition to frequencies of overall deaths at each age, we also
determined which causes of death were age related in the two spe-
cies (absolute number of deaths increase with age) by plotting den-
sity plots across the lifespan for all process (Figure 5) and system
(Figure 6) causes of death. For both species, the majority of PP
causes of death were age related with the exception of congenital
and traumatic categories in both species, and infectious and toxic
categories in dogs only. In both species, all OS causes of death
showed increasing numbers with age.
3 | DISCUSSION
Many authors have pointed out that age is the single greatest risk
factor for a variety of causes of death (Finkel, 2005; Kaeberlein
et al., 2015; Kennedy et al., 2014). However, with few exceptions,
we know relatively little about the factors that determine how age
shapes disease risk, why rates of aging (i.e., age-specific rates of
increase) differ among diseases, and why some diseases show rela-
tively few signs of aging at all. In some cases, most notably cancer,
we have been able to develop mathematical models that are consis-
tent with age trajectories (Armitage & Doll, 1954; Frank, 2007).
In both humans and dogs, cancer is a leading cause of death, and
age trajectories of cancer deaths are almost identical between the
two species (Figure 3). This suggests that, as some previous studies
have suggested, the domestic dog is an ideal model for understand-
ing human cancer (Marconato, Gelain & Comazzi, 2013; Rowell,
McCarthy & Alvarez, 2011). However, when we analyzed the speci-
fic types of neoplasia associated with death in the two species, we
found significant differences. Respiratory, urogenital, and gastroin-
testinal cancers were more common causes of death in humans com-
pared to dogs. These three particular cancers are highly associated
with lifestyle factors, including smoking, obesity, and diet. Thus, if
we could reduce the number of human cancer deaths due to lifestyle
factors, we might see a shift in the overall distribution of different
types of cancer in humans to one more closely resembling that in
dogs.
Similar age-specific trajectories were also seen between the two
species with respect to congenital and metabolic causes of death.
Given that congenital causes of death affect early-age mortality, it
makes intuitive sense that the overall age distribution is similar in
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F IGURE 2 Correlation between pathophysiological process (a),
organ system (b), and specific cancer (c) causes of death in humans
and dogs in the VMDB database (1984–2004). (a) Correlation
p = .58 by Spearman rank test, q = 0.238. Removing vascular causes
of death results in a significant correlation between humans and
dogs (q = 0.857, p = .023). (b) Spearman rank q = 0.733, p = .031.
(c) For those causes of death that had a “neoplastic” process, graph
depicts the organ systems in which cancer occurred. Spearman rank
q = 0.661, p = .053
4 of 13 | HOFFMAN ET AL.
both species. Similarities in the age distribution of the metabolic
causes of death were also notable. Metabolic causes of death are
often associated with lifestyle factors, especially obesity, and are
projected to increase in prevalence as rates of obesity increase in
humans in the United States (Flegal, Carroll, Kit & Ogden, 2012).
Interestingly, in our comorbidity analysis (number of diagnoses
recorded for dogs with a specific morbidity of interest), the diagnosis
of obesity in dogs was associated with more than double the num-
ber of comorbidities as the overall population. This is similar to
results seen in humans, in which obesity is associated with more
chronic conditions than smoking or excessive drinking (Sturm, 2002),
and previous research has shown that obese humans are more likely
to own obese dogs (Nijland, Stam & Seidell, 2010). However, it
should be noted that because of the varied morphology of dogs, a
reliable BMI metric has proved elusive, and a semi-quantitative body
condition score (BCS) is customarily used by veterinarians. As such,
while obesity diagnoses in the VMDB were assigned by attending
veterinarians, there is not a numeric BMI which can be referenced
for each of these diagnoses. Combined, the dog is well positioned to
be an excellent model of obesity and metabolic disorders.
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While many causes of death in dogs and humans share similar
relative age distributions, cardiovascular disease stands out as being
strikingly different between the two species. The reduced prevalence
of heart disease as a cause of death in canines is interesting consid-
ering dogs share many environmental influences with humans. A
large proportion of companion dogs in the United States are obese
(Freeman et al., 2006), yet dogs are rarely diagnosed with myocardial
infarction. This is due at least in part to dogs having blood choles-
terol profiles associated with a low risk of cardiovascular disease
with elevated high-density lipoprotein and reduced low-density
lipoprotein profiles (Tsutsumi, Hagi & Inoue, 2001). As a result, dogs
do not develop atherosclerosis except in rare cases when a concur-
rent condition causes a dramatic increase in total cholesterol levels
(e.g., diabetes and hypothyroidism) (Hess, Kass & Van Winkle, 2003).
Given the lack of similarity between dogs and humans in patterns of
cardiovascular disease and its attendant risks, some might argue that
the dog is a less than ideal model for human vascular diseases. At
the same time, this stark difference in risk despite similar environ-
ments suggests that close genetic and physiological analysis of the
differences between humans and dogs could shed light on
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mechanisms that enhance species resilience against myocardial
infarctions, even in the presence of specific risk factors.
As expected, we found that most causes of death in both species
were highly age related, even for those disorders whose proportional
contribution to overall deaths declined at late age compared to ear-
lier ages. Both species show a decline with age in proportions of
congenital and traumatic causes of death. While the curves are simi-
lar, total numbers of traumatic death are quite different, with many
more canines presenting with traumatic deaths. Interestingly, while
infectious disease causes of death are age related in human popula-
tions, this is not the case in the canine population, in which numbers
of individuals dying of infectious diseases do not increase with age.
In a similar vein, inflammatory causes of death peak early in the life
course of the dog while showing increases in later ages in humans.
Different inflammatory and immune responses exist between the
dog and human, although some studies point to similarities in age-
related patterns of immune markers. Previous research has shown
age-related declines in immune markers in companion dogs (Greeley,
Kealy, Ballam, Lawler & Segre, 1996; Greeley et al., 2001), as well as
age-associated changes in inflammatory markers (Alexander, Colyer,
Haydock, Hayek & Park, 2017), similar to humans. Future studies are
necessary to understand why many similar changes in immune and
inflammatory response with age are seen, yet differences in mortal-
ity between the two species are observed.
In addition to direct causes of death, the co-existence of multiple
chronic conditions within individual patients has been a large focus
in aging research due to the increasing prevalence of multimorbidity
in developed nations (Wolff, Starfield & Anderson, 2002), and evi-
dence that increased numbers of chronic conditions are associated
with decreased life expectancy (DuGoff, Canudas-Romo, Buttorff,
Leff & Anderson, 2014). Our multimorbidity analysis suggests that
companion dogs have the potential to be an excellent model to bet-
ter understand the causes and consequences of multiple chronic
conditions as we age. Similar to previous results reported by our lab-
oratory (Jin et al., 2016), multimorbidity (total number of diagnoses
recorded at the time of death) increases with age in the dog as is
seen in human populations (Fortin, Bravo, Hudon, Vanasse &
Lapointe, 2005). In addition, comorbidities vary significantly among
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different chronic conditions in the dog (Figure 3). It should be noted,
however, that we found no significant effects of sex on multimorbid-
ity numbers, which is in line with previous results suggesting no sex
difference in longevity nor cause of death in the dog (Hoffman et al.,
2017). This contrasts with results seen in humans, where women
tend to have higher rates of multimorbidity than men (Agur, McLean,
Hunt, Guthrie & Mercer, 2016).
The similarity between our canine analysis and previous human
studies with respect to patterns of comorbidity suggests the com-
panion dog may provide an ideal model to study multimorbidity
(multiple chronic conditions) and comorbidity (additional diagnoses
concurrent with a specific diagnosis of interest) in a way far superior
to other model organisms. The companion dog’s significantly shorter
lifespan, median of 12 years (O’Neill, Church, McGreevy, Thomson &
Brodbelt, 2013), than that of humans could allow us to understand
the consequences of multiple chronic conditions in longitudinal stud-
ies lasting just a few years instead of the decades needed for human
studies.
Finally, in addition to the translational value of many aspects of
canine aging for human medicine, and the obvious direct benefit of
improved healthspan to the dogs themselves, research on canines
has the potential to provide diverse benefits to human quality of life.
Dogs are utilized in many working capacities including service dogs,
police dogs, and livestock guard dogs. Training these dogs often
takes an investment of many months to years, plus thousands of
dollars (National Police Dog Foundation; Wirth & Rein, 2008), and
improving their healthspan could give humans more working years
with each dog. In addition to working roles, dogs can reduce stress
and improve emotional well-being in their owners, increasing human
quality of life (Friedmann & Son, 2009; Ownby, Johnson & Peterson,
2002; Virues-Ortega & Buela-Casal, 2006; Walsh, 2009). Thus, iden-
tifying ways to improve canine healthspan could not only have a
translational impact on humans, but could also have significant direct
economic and personal benefits for people.
3.1 | Caveats
While our analyses suggest that companion dogs hold out great pro-
mise as a model of human aging and disease, there are several limi-
tations to this study. First, much of our canine data may reflect only
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a subset of the general canine population. The VMDB data consist
of data from dogs that were seen at veterinary teaching hospitals.
Patients at these tertiary care facilities are more likely to present
with cancers and rare or serious diseases (Bartlett, Van Buren,
Neterer & Zhou, 2010). Also, the VMDB age data are collapsed into
bins. We might know that a particular dog died somewhere between
the ages of 10 and 15, for example, but not its exact age. While we
can fit parametric models to these data using interval-censored mod-
els (e.g., Kraus, Pavard & Promislow, 2013), there is considerable
error in these estimates. Also, the VMDB data include only the diag-
noses given to each dog and do not specify the diagnostic path that
was pursued to achieve the diagnoses. Thus, we cannot know, for
example, whether an infectious disease diagnosis was reached by
serologic or molecular testing, and whether a neurologic diagnosis
was achieved by clinical signs, diagnostic imaging, histopathology, or
a combination of those. The VetCompass dataset provides more
accurate age information, but does not have detailed cause of death
information nor does it capture all comorbid diagnoses that each
dog had at the time of death.
In addition, neither dataset includes information about previous
diseases or the environments in which the dogs resided. This
includes the diets the dogs were fed by their owners. Commercial
pet diets make up over 90% of all food fed to companion dogs, but
these vary greatly in nutritional profiles, similar to diets in humans.
As it would be expected that diet will have a significant contribution
to the development of morbidities in the dog just as seen in humans,
future prospective studies are needed to ascertain the extent to
which individual diets affect morbidity and lifespan in the dog.
Finally, our canine analysis makes the assumption that all dogs are
drawn from the same pool and does not look at the effects of breed
and size variation. Previous research has shown that even within a
size class, breeds can differ in their multimorbidity (Jin et al., 2016)
and mortality patterns (Fleming et al., 2011). Taken together, these
limitations point to the need for more detailed data from canines
representing the full diversity of ages, breeds, comorbidities, and
environments. Ideally, data from a prospective longitudinal study of
aging in dogs would allow us to more accurately determine how
morbidity and mortality correlate between dogs and humans (Kae-
berlein, Creevy & Promislow, 2016), and the role of multiple morbidi-
ties, both as cause and consequence, in the aging process.
We could not ascertain comorbidities from the U.S. Census
human data. For more accurate comparisons between humans and
dogs, all environmental conditions and morbidities throughout life
need to be studied. Currently, many human questions are being
answered by long-term longitudinal studies (Shock et al., 1984), and
a dog longitudinal study would nicely complement these studies
already being completed in humans. While these human studies have
been ongoing for decades, a canine longitudinal study could be com-
pleted before human studies end due to the shorter lifespans of the
animals (<20 years).
Finally, one detriment to working with the dog as a model for
human health is that our companion animals are often euthanized
when their quality of life becomes low. In the UK, 86.4% of dogs are
recorded as dying by euthanasia (O’Neill et al., 2013). This can make
it difficult to ascertain an actual cause of death as owners may elect
to euthanize a dog who could conceivably have survived the current
diagnosis and experienced a later, alternate cause of death. This is a
consideration to include with any companion animal model system as
it introduces some bias into determining actual causes of death. Para-
doxically, this may also improve the usefulness of canine data for
aging studies, especially those with measures of healthspan, defined
as the number of healthy years of life. Many euthanasia decisions are
based on the owner’s perception that the quality of life (both present
and future) has dipped below an acceptable level and therefore the
medical causes for euthanasia decisions may be very useful metrics
for healthspan. Conversely, in humans, the drive to life extension
means that many persons will have remedial and palliative manage-
ment of initial severe conditions such that they die later of secondary
but noninciting causes. Therefore, the cause of death data may not
truly describe the most important morbidities that end an individual’s
healthspan but may instead feature the terminal events that led to
the death. Euthanasia in dogs provides a potential endpoint of health-
span such that we can discern those morbidities that are associated
with the end of an individual’s healthy lifespan.
4 | CONCLUSIONS
Here, we have presented a large-scale comparison of human and
companion dog mortality. The study findings suggest the dog could
be an excellent model to study diverse causes of morbidity and mor-
tality that also affect humans. However, many data are still lacking.
A long-term longitudinal study of aging in domestic dogs, represent-
ing a diversity of genotypes and environments, would allow for a
more accurate understanding of the promises and pitfalls of the
companion dog as a model of human morbidity and mortality.
5 | EXPERIMENTAL PROCEDURES
5.1 | Human morbidity and mortality data
We obtained human mortality data from the U.S. Census Bureau’s
National Longitudinal Mortality Study, which was carried out over a
20-year period starting in the early 1970s (1973–2002, U.S. Census
Bureau). All individuals were followed for 10 years (in two separate
cohorts), and for those who died during this period, age and cause
of death were recorded. These causes of death were then assigned
to a specific pathophysiological process (PP) and organ system (OS)
as described previously in Fleming et al. (2011), such that each indi-
vidual had both a process and system classification of death. Patho-
physiological process describes the mechanism leading to the disease
and includes congenital, degenerative, infectious, inflammatory (en-
compassing immune-mediated), metabolic, neoplastic, toxic, trau-
matic, and vascular. Organ system designates the primary organ
system that was affected and includes cardiovascular, dermatologic,
endocrine, gastrointestinal, hematopoietic, hepatic, musculoskeletal,
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neurologic, ophthalmologic, respiratory, and urogenital. The option of
“unclassified” existed for both pathophysiological process and organ
system, for those diagnoses too general or vague to be assigned
with certainty. Human causes of death were assigned OS and PP
classifications identical to those used for the canine dataset (de-
scribed below). For rare causes of death that were novel to the
human dataset, one of the authors (KEC) assigned a PP and OS in
the same manner.
Canine data were collected from two sources. First, we obtained
data on cause of death and multimorbidity for dogs from the Veteri-
nary Medical Database (VMDB, https://vmdb.org),1 which contains
abstracted medical record information submitted by the 27 participat-
ing Veterinary Teaching Hospitals in North America. Data obtained
included all diagnoses recorded by the attending veterinarians at the
time of death for all dogs whose death was documented in the VMDB
between 1984 and 2004 (N = 73,835 dogs; mean number of diag-
noses = 2.97; range of 1–32). For dogs with multiple diagnoses, a sin-
gle cause of death, including process and system, has been assigned
previously (Fleming et al., 2011). Age at death in the VMDB was
grouped into bins. We combined the three youngest bins (0–2 weeks,
2 weeks-2 months, and 2–6 months) into one group labeled
0.25 years; for all other age bins, midpoint ages for each bin were used
as in Hoffman, Creevy and Promislow (2013). Animals in the “over
15 years” bin were represented with an age of 17.5 years.
We obtained a second set of canine data, including exact age
and cause of death, from the VetCompass Programme database,
maintained by the Royal Veterinary College in the United Kingdom
(O’Neill, Church, McGreevy, Thomson & Brodbelt, 2014). Because
the VMDB represents Veterinary Teaching Hospital patients, it is
subject to referral bias (Bartlett et al., 2010), meaning these patients
likely exhibit more severe, complicated, or unusual diseases that are
seen in the canine population at large, and average income of clients
might be higher than that for all dog owners. By contrast, the
VetCompass dataset is comprised of complete clinical records from
primary care veterinary practices, and as such might provide a better
representation of the canine population as a whole. While causes of
death were recorded for all dogs, data were grouped into a limited
set of 56 specific causes, prior to our obtaining the data. Due to
overlap in many of the diagnoses, OS and PP classifications could
not be completely assigned as was done with Census and VMDB
data. Ethical approval for the VetCompass component of the study
was granted by the Royal Veterinary College Ethics and Welfare
Committee (reference number 2015/1369).
5.2 | Analyses
All statistical analyses were carried out using the R programming lan-
guage (R Core Team 2013).
5.3 | Mortality analyses
We first plotted Kaplan–Meier survival curves for the humans and
dogs, keeping the sexes separate. We used a Cox proportional
hazard model to determine significant sex effects within each spe-
cies. We then computed log10 hazard mortality values using the
muhaz package. We used the flexsurv package to determine parame-
ter values for the Gompertz equation, l0 = ae
bx, where lx is the
instantaneous rate of mortality at age x. Gompertz curves are typi-
cally plotted on a log-linear scale: log(lx) = log(a) + bx. The slope of
this line, b, is considered the rate of aging. For this analysis, we
included the human data and the VetCompass canine data only, due
to the large age bins of the VMDB data.
5.4 | Canine multimorbidity and comorbidity
analyses
While the VMDB does not include information on multiple chronic
conditions experienced throughout the lifetime in an individual, we
were able to explore the relationships among age and cause of death
and number of morbidities at time of death. For this analysis, multi-
morbidity was defined as the total number of diagnoses recorded at
the time of death (Jin et al., 2016), and comorbidity was defined as
the number of diagnoses recorded for a dog with a specific morbid-
ity of interest, excluding the specific morbidity of interest. Each diag-
nosis was weighted equally in our calculation of comorbidity or
multimorbidity, regardless of the relative severity of each particular
diagnosis. Causes of death that were recorded as “unclassified” in
the VMDB were removed, as were all cases in which the only diag-
nosis was “euthanasia”.
Using the canine VMDB dataset, we first determined how the
number of diagnoses changed with age across both sexes using a
generalized linear model (GLM), where the dependent variable,
multimorbidity, was assigned a negative binomial distribution (Jin
et al., 2016). We modeled the impacts of sex and age on
morbidity score as fixed effects. Next, we analyzed specific PP
and OS categories as described previously (Fleming et al., 2011)
to determine whether dogs with certain categorical causes of
death exhibited greater multimorbidities than the rest of the
population. We used a GLM with pathophysiological process (or
organ system), age, and sex as fixed effects as predictors of total
number of diagnoses, for which we assumed a negative binomial
distribution.
To create a direct comparison between patterns of comorbidity
in dogs and humans, we were interested in associations of comor-
bidities with certain discrete diagnoses that had been entered for
individual dogs by their attending veterinarians at the time of the
dogs’ death. We looked at comorbidity counts associated with each
of five specific diagnoses that are common chronic conditions in
both the dog and the human: diabetes mellitus, arthritis, obesity,
hypothyroidism, and chronic kidney disease. We used these data to
determine whether dogs with these particular diagnoses were more
likely to have higher comorbidity counts than dogs without these
diagnoses. Similar to our multimorbidity analysis, we considered
every diagnosis in each individual dog as a morbidity regardless of
the seriousness of the condition. For each morbidity of interest, we
ran a GLM with a negative binomial distribution, with the morbidity
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of interest, age, and sex as fixed effects predicting comorbidity
number.
5.5 | Human–dog comparisons
Our final analysis determined similarities of causes of death between
humans and dogs. We first looked at the associations between per-
centage of deaths for all PP and OS categories in the human and the
VMDB canine dataset using a Spearman rank correlation analysis.
Next, we compared causes of death as a function of age for the
same PP and OS categories for both humans and dogs. For these
analyses, for all individuals who died at a specific age, we estimated
the proportion who died of each specific PP/OS. We modeled each
cause of death as a function of age using a multinomial logistic
regression. For each species (dog and human) and cause of death,
we modeled the log odds of death in each group as a fourth-order
polynomial in age:
pgroupðageÞ ¼ softmax agroup þ
X4
i¼1 b
i
groupage
i
 
(1)
where softmaxðzÞi ¼ expðziÞ=
P
j expðzjÞ
 
. To facilitate direct com-
parison, we rescaled dog age to human age by aligning the neoplas-
tic death curves in humans and dogs. Specifically, to align the
curves, we found the age at which the proportion of neoplastic
deaths is the highest for both humans (53 years) and dogs
(11.5 years). This led to one dog year corresponding to approxi-
mately 53/11.5 = 4.6 human years. Note that this was derived from
analysis using data for all dogs. Scaling would differ for specific
breeds as lifespan and risk of cancer vary among breeds. This breed-
specific analysis is beyond the scope of the current analysis and will
be explored in the future.
We also included an explicit comparison between humans and
dogs by computing the log2 odds ratio of death for each cause
between humans and dogs:
log 2odds ratio ¼ logitðphumanðageÞÞ  logitðpdogðrescaled ageÞÞ (2)
where logitðpÞ ¼ log 2ðp=ð1 pÞÞ. This quantity tells us how the
relative risk of death associated with a given cause occurring
changes with age. When the log odds ratio is zero for a particular
cause at a given age, this tells us that the odds of this cause of
death are the same for dogs and humans. When it is positive, this
cause of death is more likely in humans, and conversely when it is
negative the cause is more likely in dogs. We then colored a few
key groups (PP: vascular, metabolic, and neoplastic; OS: cardiovascu-
lar, endocrine, and hepatic) and plotted the other groups in light
gray. We also plotted absolute percentages of individuals that died
of specific causes at each age to discover which causes of death in
both sexes were age related.
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